ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sarepta Therapeutics, Inc. clinical trials

Also known as AVI BioPharma.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 52 studies whose lead sponsor is Sarepta Therapeutics, Inc. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Sarepta Therapeutics with Novartis and Teva Pharmaceutical Industries →

Pipeline: 4 programs

Each counted once: 4 with a study Sarepta Therapeutics, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sarepta Therapeutics, Inc.’s own registered studies; Sarepta Therapeutics, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Sarepta Therapeutics, Inc.’s studies test, most studies first; none is open now — 5 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

4 of Sarepta Therapeutics, Inc.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. 1N

Add all 4 to your calendar (.ics) → With an account.

All 52 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now815%Enrolling by invitation 5 · Recruiting 3
  • Under way, not recruiting48%
  • Completed2446%
  • Stopped early1631%Terminated 14 · Withdrawn 2

Phase

  • Phase 130
  • Phase 219
  • Phase 39
  • Phase 41

Where

  • United States39
  • United Kingdom15
  • Italy14
  • Spain12
  • Germany12
  • Belgium11

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 618
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sarepta Therapeutics, Inc.

  • Sarepta Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    52 studies

Focus areas

Conditions Sarepta Therapeutics, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 52. Browse all 52 →